NEW YORK (Reuters) - Gene-testing technology company Illumina Inc. will acquire Solexa Inc. in a stock deal valuing the developer of genetic analysis systems at about $600 million, the companies said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results